Volume 5, Issue 1
Editorialp. 1–3
Sex, gender and clinical research: have you considered the possibilities?
Author(s): Joy Johnson
Editorialp. 5–7
Improving the implementation of evidence-based knowledge in healthcare
Author(s): Bernard Burnand
Drug Evaluation
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Author(s): Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluationp. 23–38
Review of tofacitinib in rheumatoid arthritis
Author(s): Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Perspectivep. 39–46
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Author(s): Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Review Article
Angiokinase inhibitors in non-small-cell lung cancer
Author(s): Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Clinical Trail Methodologyp. 61–74
Application of biomarkers in oncology clinical trials
Author(s): Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Outcomesp. 75–87
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Author(s): Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomesp. 89–110
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Author(s): Ali J Mahdi, Eamon J Mahdi & Steven Knapper
